Pearson plc
NYSE:PSOPublishing
-$0.11 today
- Market cap
- $10.27B
- Beta
- -0.04
- P/E (TTM)
- 21.4
- EPS (TTM)
- $0.53
- Dividend yield
- 2.24%
Volume 0.58M
Average 1.04M
PSO EBITDA Margin
EBITDA as a percentage of revenue.
Pearson plcNYSE: PSO
EBITDA Margin · Q4 FY2025 · quarter ended Dec 2025
EBITDA Margin narrows to 33.3%
EBITDA Margin was 33.3% in Q4 FY2025, down 12.3 pp from a year earlier. Over 3 fiscal years it widened by 6.6 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 6 analysts of 29.9% for the fiscal year ending Dec 2026, down from 30.8% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterDec 2025
- 33.3%— QoQ
- Last fiscal yearDec 2025
- 30.8%-0.6 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -12.3 pp | — | — |
| 1 year | -0.6 pp | -0.9 pp | -0.4 pp |
| 3 years | +6.6 pp | -3.4 pp | -10.1 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 30.8%
- Year-over-year change
- -0.6pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 30.8% | -0.6pp |
| FY2024 | 2024-12-31 | 31.4% | +1.5pp |
| FY2023 | 2023-12-31 | 29.9% | +5.6pp |
| FY2022 | 2022-12-31 | 24.2% | +2.3pp |
| FY2021 | 2021-12-31 | 21.9% | — |
EBITDA Margin vs competitors
How PSO compares with its peers on the latest reported figures
- PSO's FY2025 EBITDA Margin of 30.8% is the 3rd highest of the 10 companies compared; the peer median is 18.0%.
- Its year-over-year change of -0.6 pp is the 7th highest of 10, against a peer median of +1.2 pp.
- Over three fiscal years its change of +6.6 pp compares with a peer median of +4.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 39.5% | +11.0 pp | -0.9 pp | |
MHMcGraw Hill, Inc. | LTM Jun 2026 | 31.4% | -0.9 pp | +6.8 pp |
| FY2025 | 30.8% | -0.6 pp | +6.6 pp | |
| LTM Jun 2026 | 23.0% | +1.9 pp | +7.2 pp | |
| LTM Jul 2026 | 22.7% | +2.6 pp | +10.1 pp | |
| LTM Mar 2026 | 18.0% | +1.2 pp | +4.9 pp | |
| LTM Feb 2026 | 13.6% | +7.6 pp | -3.1 pp | |
| LTM Mar 2026 | 13.6% | -14.9 pp | +2.2 pp | |
| LTM Apr 2026 | 10.2% | -0.1 pp | +113.7 pp | |
| LTM Mar 2026 | 10.1% | -1.1 pp | +4.1 pp | |
| Peer median (excluding PSO) | 18.0% | +1.2 pp | +4.9 pp | |
Competitors are the stored peer set for PSO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.43B | 3.84B | 3.67B | 3.55B | 3.58B |
| Cost of Revenue | 1.75B | 2.05B | 1.84B | 1.74B | 1.72B |
| Gross Profit | 1.68B | 1.8B | 1.84B | 1.81B | 1.86B |
| Gross Margin | 49.0% | 46.7% | 49.9% | 51.0% | 52.0% |
| Research & Development | 279M | 303M | 284M | 291M | 0 |
| Selling, General & Admin | 1.39B | 1.45B | 1.36B | 1.31B | 1.3B |
| Operating Expenses | 1.5B | 1.52B | 1.34B | 1.27B | 1.26B |
| Depreciation & Amortization | 518M | 551M | 543M | 526M | 571M |
| EBITDA | 751M | 930M | 1.1B | 1.12B | 1.1B |
| EBITDA Margin | 21.9% | 24.2% | 29.9% | 31.4% | 30.8% |
| Operating Income | 183M | 271M | 498M | 541M | 618.15M |
| Operating Margin | 5.3% | 7.1% | 13.6% | 15.2% | 17.3% |
| Interest Income | 15M | 67M | 50M | 55M | 16.63M |
| Interest Expense | 68M | 69M | 61M | 79M | 69.44M |
| Other Income / Expenses | (6M) | 51M | (5M) | (31M) | (171.16M) |
| Income Before Tax | 177M | 322M | 493M | 510M | 446.99M |
| Pre-Tax Margin | 5.2% | 8.4% | 13.4% | 14.4% | 12.5% |
| Income Tax Expense | (1M) | 79M | 113M | 75M | 118.35M |
| Net Income | 177M | 242M | 378M | 434M | 327.66M |
| Net Margin | 5.2% | 6.3% | 10.3% | 12.2% | 9.2% |
| EPS (Basic) | 0.23 | 0.33 | 0.53 | 0.63 | 0.50 |
| EPS (Diluted) | 0.23 | 0.33 | 0.53 | 0.63 | 0.50 |
| Weighted Avg Shares | 754.1M | 738.1M | 717.27M | 688.6M | 651.3M |
| Weighted Avg Shares (Diluted) | 759.1M | 742M | 717.3M | 684M | 660.3M |
Pearson plc
NYSE:PSO
Intrinsic Alpha fair value
Locked
Current Price
$17.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.